3 completed, 2 terminated. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Phase 1 | 2 | Completed 2 |
Follow PF-04136309: new trials by email Literature Review of PF-04136309 trials Research Report on PF-04136309
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients PF-04136309, Nab-paclitaxel, Gemcitabine - Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | Terminated | Pfizer | 22 | 2016-05-04 | 2019-02-04 |
| Food Effect Study PF-04136309 PF-04136309 - Healthy | Phase 1 | Completed | Pfizer | 18 | 2015-12-01 | 2018-04-11 |
| FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma Oxaliplatin, Irinotecan, Leucovorin - Pancreatic Neoplasms | Phase 1 | Completed | Washington University School of Medicine | 44 | 2012-04-01 | 2016-09-19 |
| Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes Placebo, PF-04136309 - Hepatitis C, Chronic | Phase 2 | Terminated | Pfizer | 24 | 2011-01-17 | 2023-07-27 |
| Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee PF-04136309, Placebo - Osteoarthritis, Knee | Phase 2 | Completed | Pfizer | 159 | 2008-08-05 | 2021-07-13 |
Hepatitis C (1) · Hepatitis C, Chronic (1) · Osteoarthritis, Knee (1) · Pancreatic Neoplasms (1)
Pfizer (4) · Washington University School of Medicine (1)
United States (3) · South Korea (2) · Belgium (1) · Hong Kong (1) · India (1) · Singapore (1) · Taiwan (1)
Andrea Wang-Gillam, M.D., PhD (1)
2015 (2)